Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults

This study has been completed.
Vaccine Technologies Inc.
Siriraj Hospital, Mahidol University
Information provided by (Responsible Party):
International Vaccine Institute Identifier:
First received: August 25, 2008
Last updated: March 29, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)